{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:55:26Z","timestamp":1790999726728,"version":"4.1.0"},"reference-count":26,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1297\/cpe.2025-0135","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:10:07Z","timestamp":1783030207000},"page":"364-371","source":"Crossref","is-referenced-by-count":0,"title":["A case of congenital hyperinsulinism with <i>ABCC8<\/i> variants treated with octreotide long-acting release for four years"],"prefix":"10.1297","volume":"35","author":[{"given":"Ikumi","family":"Umeki","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"},{"name":"Department of Pediatrics, Iwate Prefectural Central Hospital, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinobu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisumi","family":"Sogi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"},{"name":"Department of Pediatrics, Japan Community Health Care Organization Sendai Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Soma General Hospital, Soma, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ohara General Hospital, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Ohara General Hospital, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Genetics Medicine, Osaka City General Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yorifuji","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Date Red Cross Hospital, Date, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tohoku University Hospital, Sendai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kapoor, RR, Flanagan, SE, Arya, VB, Shield, JP, Ellard, S, Hussain, K. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol 2013;168: 557\u201364.","DOI":"10.1530\/EJE-12-0673"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Menni, F, de Lonlay, P, Sevin, C, Touati, G, Peign\u00e9, C, Barbier, V, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001;107: 476\u20139.","DOI":"10.1542\/peds.107.3.476"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tyrrell, VJ, Ambler, GR, Yeow, WH, Cowell, CT, Silink, M. Ten years\u2019 experience of persistent hyperinsulinaemic hypoglycaemia of infancy. J Paediatr Child Health 2001;37: 483\u20138.","DOI":"10.1046\/j.1440-1754.2001.00748.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Giurgea, I, Sempoux, C, Bellann\u00e9-Chantelot, C, Ribeiro, M, Hubert, L, Boddaert, N, et al. The Knudson\u2019s two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism. J Clin Endocrinol Metab 2006;91: 4118\u201323.","DOI":"10.1210\/jc.2006-0397"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Damaj, L, le Lorch, M, Verkarre, V, Werl, C, Hubert, L, Nihoul-F\u00e9k\u00e9t\u00e9, C, et al. Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. J Clin Endocrinol Metab 2008;93: 4941\u20137.","DOI":"10.1210\/jc.2008-0673"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wieland, I., Schanze, I., Felgendreher, I. M., Barthlen, W., Vogelgesang, S., Mohnike, K. and Zenker, M. Integration of genomic analysis and transcript expression of ABCC8 and KCNJ11 in focal form of congenital hyperinsulinism. Front Endocrinol (Lausanne) 2022;13: 1015244.","DOI":"10.3389\/fendo.2022.1015244"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Arya, VB, Senniappan, S, Demirbilek, H, Alam, S, Flanagan, SE, Ellard, S, et al. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS One 2014;9: e98054.","DOI":"10.1371\/journal.pone.0098054"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zobel, MJ, McFarland, C, Ferrera-Cook, CT, Padilla, BE. Surgical management of medically-refractory hyperinsulinism. Am J Surg 2020;219: 947\u201351.","DOI":"10.1016\/j.amjsurg.2019.09.003"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Snider, KE, Becker, S, Boyajian, L, Shyng, SL, MacMullen, C, Hughes, N, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98: E355\u201363.","DOI":"10.1210\/jc.2012-2169"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Demirbilek, H, Hussain, K. Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocrinol 2017;9(Suppl 2): 69\u201387.","DOI":"10.4274\/jcrpe.2017.S007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lord, K, De Le\u00f3n, DD. Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. Int J Pediatr Endocrinol 2013;2013: 3.","DOI":"10.1186\/1687-9856-2013-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ampofo, E, Nalbach, L, Menger, MD, Laschke, MW. Regulatory mechanisms of somatostatin expression. Int J Mol Sci 2020;21: 4170.","DOI":"10.3390\/ijms21114170"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. van der Steen, I, van Albada, ME, Mohnike, K, Christesen, HT, Empting, S, Salomon-Estebanez, M, et al. A multicenter experience with long-acting somatostatin analogues in patients with congenital hyperinsulinism. Horm Res Paediatr 2018;89: 82\u20139.","DOI":"10.1159\/000485184"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Narayanan, S, Kunz, PL. Role of somatostatin analogues in the treatment of neuroendocrine tumors. J Natl Compr Canc Netw 2015;13: 109\u201317, quiz 117.","DOI":"10.6004\/jnccn.2015.0012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Feelders, RA, Hofland, LJ, van Aken, MO, Neggers, SJ, Lamberts, SW, de Herder, WW, et al. Medical therapy of acromegaly: efficacy and safety of somatostatin analogues. Drugs 2009;69: 2207\u201326.","DOI":"10.2165\/11318510-000000000-00000"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Le Quan Sang, KH, Arnoux, JB, Mamoune, A, Saint-Martin, C, Bellann\u00e9-Chantelot, C, Valayannopoulos, V, et al. Successful treatment of congenital hyperinsulinism with long-acting release octreotide. Eur J Endocrinol 2012;166: 333\u20139.","DOI":"10.1530\/EJE-11-0874"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kubsad, PS, Vani, HN, Sheshadri, T, Palany, R. Clinical profile and efficacy of long-acting octreotide in hyperinsulinemic hypoglycaemia. Indian J Endocrinol Metab 2024;28: 289\u201394.","DOI":"10.4103\/ijem.ijem_483_23"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Karlekar, MP, Sarathi, V, Arya, S, Flanagan, SE, Patil, V, Lila, A, et al. Octreotide-LAR is a useful alternative for the management of diazoxide-responsive congenital hyperinsulinism. Horm Metab Res 2021;53: 723\u20139.","DOI":"10.1055\/a-1654-8542"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Clemente, M, Cobo, P, Antol\u00edn, M, Campos, A, Yeste, D, Tomasini, R, et al. Genetics and natural history of non-pancreatectomized patients with congenital hyperinsulinism due to variants in ABCC8. J Clin Endocrinol Metab 2023;108: e1316\u201328.","DOI":"10.1210\/clinem\/dgad280"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Laje, P, Halaby, L, Adzick, NS, Stanley, CA. Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatr Diabetes 2010;11: 142\u20137.","DOI":"10.1111\/j.1399-5448.2009.00547.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Modan-Moses, D, Koren, I, Mazor-Aronovitch, K, Pinhas-Hamiel, O, Landau, H. Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). J Clin Endocrinol Metab 2011;96: 2312\u20137.","DOI":"10.1210\/jc.2011-0605"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. K\u00fchnen, P, Marquard, J, Ernert, A, Meissner, T, Raile, K, Wannenmacher, G, et al. Long-term lanreotide treatment in six patients with congenital hyperinsulinism. Horm Res Paediatr 2012;78: 106\u201312.","DOI":"10.1159\/000341525"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shah, P, Rahman, SA, McElroy, S, Gilbert, C, Morgan, K, Hinchey, L, et al. Use of long-acting somatostatin analogue (lanreotide) in an adolescent with diazoxide-responsive congenital hyperinsulinism and its psychological impact. Horm Res Paediatr 2015;84: 355\u201360.","DOI":"10.1159\/000439131"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Giri, D, Price, V, Yung, Z, Didi, M, Senniappan, S. Fluoxetine-induced hypoglycaemia in a patient with congenital hyperinsulinism on lanreotide therapy. J Clin Res Pediatr Endocrinol 2016;8: 347\u201350.","DOI":"10.4274\/jcrpe.2818"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Corda, H, Kummer, S, Welters, A, Teig, N, Klee, D, Mayatepek, E, et al. Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism. Orphanet J Rare Dis 2017;12: 108.","DOI":"10.1186\/s13023-017-0653-x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mooij, CF, Tacke, CE, van Albada, ME, Barthlen, W, Bikker, H, Mohnike, K, et al. Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation. Ann Pediatr Endocrinol Metab 2021;26: 278\u201383.","DOI":"10.6065\/apem.2142010.005"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/4\/35_2025-0135\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:40:43Z","timestamp":1790998843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/35\/4\/35_2025-0135\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2025-0135","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025-0135"}}